Matthew Kisielius

Matthew Kisielius is an Associate Director at Bristol Myers Squibb, specializing in Drug Product Lifecycle Management and Parenteral Manufacturing Science & Technology since October 2017. In this role, Matthew leads the technical agenda for a major biologics brand, collaborating with various technical teams and stakeholders to shape the strategic technology roadmap. Prior to this, Matthew served as a Principal Engineer, overseeing drug product manufacturing for biologic products at both internal and contract manufacturing sites. Matthew's extensive experience includes positions at Merck, where responsibilities ranged from serving as a Subject Matter Expert in liquid vaccine formulation to managing significant engineering projects and process improvements. Matthew holds a Bachelor of Science degree in Chemical Engineering from Drexel University.